S. Evans

Statistics and Probability · Journal of the American Medical Association (JAMA) · 2001–2009

A researcher in the Science corpus: 5 papers; trusts 9 researchers and is trusted by 24 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 30 citations into it; #2,513 of 12,932 by trust here, #878 by citations
• Economics and Econometrics — 20 citations into it; #5,447 of 23,481 by trust here, #2,467 by citations
• Toxicology — 5 citations into it; #22 of 76 by trust here, #63 by citations

Whom S. Evans trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. William DuMouchel
2. Ana Szarfman
3. David Moher
4. Douglas G. Altman
5. Daryl Pregibon

Who trusts S. Evans overall

1. Andrew Bate
2. Douglas G. Altman
3. K. F. Schulz
4. Kenneth J. Rothman
5. E. von Elm
6. David Moher
7. G. Piaggio
8. Robert Eriksson
9. Nicholas P. Tatonetti
10. S. Lanes

Papers from S. Evans's perspective

Ordered by how strongly the researchers S. Evans trusts endorse each paper. Same corpus, a different order for every researcher.

1. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
2. Empirical bayes screening for multi-item associations (Knowledge Discovery and Data Mining)
3. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. (Journal of the American Medical Association (JAMA))
4. Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics (Statistics in Medicine)
5. WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. (The Lancet)
6. Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (Annals of Internal Medicine)
7. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports (Pharmacoepidemiology and Drug Safety)
8. Statistical aspects of the analysis of data from retrospective studies of disease.
9. Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database (Drug Safety)
10. A comparison of observational studies and randomized, controlled trials. (New England Journal of Medicine)

Their papers

• Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004) — 1,406 citations
• Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. (2006) — 997 citations
• Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. (2006) — 1,902 citations
• Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports (2001) — 1,699 citations
• Quantitative signal detection using spontaneous ADR reporting (2009) — 847 citations